https://scholars.lib.ntu.edu.tw/handle/123456789/480462| Title: | Chromobacterium violaceum infection in children: A case of fatal septicemia with nasopharyngeal abscess and literature review | Authors: | PEI-LAN SHAO PO-REN HSUEH Hang Y.-C.C. CHUN-YI LU Lee P.-Y. Lee C.-Y. LI-MIN HUANG |
Issue Date: | 2002 | Journal Volume: | 21 | Journal Issue: | 7 | Start page/Pages: | 707-709 | Source: | Pediatric Infectious Disease Journal | Abstract: | This previously healthy 5-year-old boy initially presented with fever and purulent conjunctivitis. The course evolved rapidly into preseptal and facial cellulitis, nasopharyngeal abscess and sepsis. Chromobacterium violaceum was isolated from conjunctival exudate and blood cultures. He received intravenous cefazolin therapy for 2 days, followed by penicillin, oxacillin and netilmicin. However, no improvement was noted, and he died on the fifth days of illness. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/480462 | ISSN: | 0891-3668 | DOI: | 10.1097/00006454-200207000-00022 | SDG/Keyword: | cefazolin; netilmicin; oxacillin; penicillin G; antiinfective agent; abscess; antibiotic therapy; article; bacterium isolation; blood culture; case report; childhood disease; Chromobacterium; chromobacterium violaceum; death; Gram negative sepsis; human; male; medical literature; preschool child; priority journal; abscess; bacteremia; classification; disease course; drug combination; fatality; Gram negative infection; hospitalization; isolation and purification; review; rhinopharyngitis; risk assessment; Abscess; Antibiotics, Combined; Bacteremia; Case Report; Child, Preschool; Chromobacterium; Disease Progression; Fatal Outcome; Gram-Negative Bacterial Infections; Human; Male; Nasopharyngitis; Risk Assessment; Severity of Illness Index; Anti-Bacterial Agents; Child, Preschool; Disease Progression; Drug Therapy, Combination; Fatal Outcome; Humans; Male; Risk Assessment; Severity of Illness Index [SDGs]SDG3 |
| Appears in Collections: | 醫學院附設醫院 (臺大醫院) |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.